Brenda Velasco - Publications
Affiliations: | 2018- | Blood and Marrow Transplantation | Stanford University School of Medicine, Palo Alto, CA, United States |
Website:
https://profiles.stanford.edu/brenda-velascoYear | Citation | Score | |||
---|---|---|---|---|---|
2022 | Chang CA, Bhagchandani P, Poyser J, Velasco BJ, Zhao W, Kwon HS, Meyer E, Shizuru JA, Kim SK. Curative islet and hematopoietic cell transplantation in diabetic mice without toxic bone marrow conditioning. Cell Reports. 41: 111615. PMID 36351397 DOI: 10.1016/j.celrep.2022.111615 | 0.719 | |||
2021 | Bankova AK, Pang W, Velasco BJ, Long-Boyle JR, Shizuru JA. 5-Azacytidine depletes hematopoietic stem cells and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice. Blood Advances. PMID 34448832 DOI: 10.1182/bloodadvances.2020003841 | 0.387 | |||
2019 | George BM, Kao KS, Kwon HS, Velasco BJ, Poyser J, Chen A, Le AC, Chhabra A, Burnett CE, Cajuste D, Hoover M, Loh KM, Shizuru JA, Weissman IL. Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance. Cell Stem Cell. PMID 31204177 DOI: 10.1016/J.Stem.2019.05.018 | 0.652 | |||
2005 | Rodríguez L, Velasco B, García J, Martín-Henao GA. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion. 45: 1391-7. PMID 16078930 DOI: 10.1111/j.1537-2995.2005.00213.x | 0.37 | |||
Show low-probability matches. |